Brief: Brenntag Pharma Signs Strategic Partnership With Evonik
BRIEF-Brenntag Pharma Signs Strategic Partnership With Evonik July 15 (Reuters) - BRENNTAG SE BNRGn.DE:
BRENNTAG PHARMA SIGNS STRATEGIC PARTNERSHIP WITH EVONIK
EXCLUSIVE DISTRIBUTION AGREEMENT FOR REXIM® AMINO ACIDS STRENGTHENS BRENNTAG'S ROLE IN BIOPHARMA AND API MARKETS
ASSUMES FULL RESPONSIBILITY FOR MARKET DEVELOPMENT AND DISTRIBUTION ACROSS MOST OF EUROPE SINCE JULY 1
Further company coverage: [BNRGn.DE]
(Reporting by Conrad Kuepper)
((Conrad.Kuepper@thomsonreuters.com;))
Recent news on Brenntag SE
See all newsBrief: Brenntag Enters Distribution Agreement With Almatis In Latin America
Brief: Brenntag And Cassava Pharma Sign Exclusive Distribution Agreement
German chemical industry mood rises for second straight month in September, Ifo says
Deutsche Bank AG FF - Post Stabilisation Notice- Brenntag Finance EUR 7y
Brief: Brenntag Global Partnership With DSM-Firmenich For Byphar Powered By Biond™